To hear about similar clinical trials, please enter your email below
Trial Title:
Human Papillomavirus in Young People Epidemiological Research 4
NCT ID:
NCT05587738
Condition:
Human Papillomavirus Infection
HPV
HPV Infection
Anal Cancer
Cancer
Men
HPV 16 Infection
Conditions: Official terms:
Infections
Communicable Diseases
Papillomavirus Infections
Anus Neoplasms
Conditions: Keywords:
Vaccination
Vaccine
Public health
Prevention
Men who have sex with men
Gay and bisexual men
Immunisation
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Cross-Sectional
Summary:
Anal cancer is overrepresented among gay, bisexual and other men who have sex with men
(MSM), particularly those living with HIV. Australia was the first country to introduce a
publicly funded national HPV vaccination program in 2007. This program was expanded to
include schoolboys aged 12-13 years in 2013; with a 2-year catch-up for boys aged up to
15 years.
The goal of the HYPER4 study is to determine the prevalence of anal, genital and oral HPV
among 500 young gay and bisexual men aged 21-25 years who were eligible for the
school-based gender-neutral quadrivalent vaccination program.
Participants will be required to complete a questionnaire and provide samples for HPV
testing. No follow-up visits will be required.
Criteria for eligibility:
Study pop:
Study participants will be recruited from sexual health clinics, community, gay community
events, universities, social networking services, and peer-referral.
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- Men aged 21 to 25 years old in 2023-2024
- Same-sex attracted
- Residing in Australia since 2013
Exclusion Criteria:
- Unable to complete all study requirements in English
Gender:
Male
Gender based:
Yes
Minimum age:
21 Years
Maximum age:
25 Years
Locations:
Facility:
Name:
Melbourne Sexual Health Centre
Address:
City:
Melbourne
Zip:
3053
Country:
Australia
Status:
Recruiting
Contact:
Last name:
Eric PF Chow, PhD
Phone:
+61393416233
Email:
eric.chow@monash.edu
Start date:
January 1, 2023
Completion date:
December 31, 2024
Lead sponsor:
Agency:
Monash University
Agency class:
Other
Collaborator:
Agency:
The Alfred
Agency class:
Other
Collaborator:
Agency:
University of Melbourne
Agency class:
Other
Source:
Monash University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05587738
